We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.56T
| $1.23B | 6.39% |
8,910,568
-678,560
| -7% | -$107M |
|
|
2
Microsoft
MSFT
$3.71T
| $1.16B | 6.01% |
4,972,772
-443,779
| -8% | -$117M |
|
3
Amazon
AMZN
$2.94T
| $429M | 2.22% |
3,795,935
+341,704
| +10% | +$43.2M |
|
|
4
Broadcom
AVGO
$2T
| $408M | 2.12% |
9,191,520
+4,389,560
| +91% | +$224M |
|
5
Tesla
TSLA
$1.26T
| $353M | 1.83% |
1,329,741
+128,133
| +11% | +$35.8M |
|
6
Qualcomm
QCOM
$168B
| $319M | 1.65% |
2,822,896
-491,030
| -15% | -$67.5M |
|
|
7
Alphabet (Google) Class A
GOOGL
$4.38T
| $291M | 1.51% |
3,040,816
-1,103,564
| -27% | -$122M |
|
|
8
UnitedHealth
UNH
$367B
| $290M | 1.5% |
573,275
+251,089
| +78% | +$132M |
|
|
9
Alphabet (Google) Class C
GOOG
$4.36T
| $284M | 1.47% |
2,953,444
-1,200,596
| -29% | -$134M |
|
10
United Parcel Service
UPS
$87.7B
| $257M | 1.33% |
1,592,575
-128,727
| -7% | -$24.4M |
|
|
11
Pfizer
PFE
$149B
| $219M | 1.14% |
5,003,226
-2,478,013
| -33% | -$120M |
|
12
Home Depot
HD
$349B
| $216M | 1.12% |
781,078
+211,185
| +37% | +$62.3M |
|
13
Lowe's Companies
LOW
$122B
| $215M | 1.12% |
1,146,574
-13,213
| -1% | -$2.57M |
|
14
Johnson & Johnson
JNJ
$619B
| $214M | 1.11% |
1,312,975
-181,773
| -12% | -$30.8M |
|
15
Accenture
ACN
$105B
| $208M | 1.08% |
809,071
-223,563
| -22% | -$64.6M |
|
16
Coca-Cola
KO
$374B
| $203M | 1.05% |
3,631,674
+235,755
| +7% | +$14.7M |
|
17
Berkshire Hathaway Class B
BRK.B
$1.13T
| $199M | 1.03% |
743,468
-99,175
| -12% | -$28.2M |
|
18
ExxonMobil
XOM
$642B
| $196M | 1.02% |
2,244,242
-40,194
| -2% | -$3.67M |
|
19
Amgen
AMGN
$219B
| $179M | 0.93% |
794,813
+36,747
| +5% | +$8.91M |
|
20
Chevron
CVX
$371B
| $179M | 0.93% |
1,245,156
-80,486
| -6% | -$12.3M |
|
21
Mastercard
MA
$505B
| $175M | 0.91% |
616,004
+189,270
| +44% | +$62.7M |
|
22
Everest Group
EG
$14.2B
| $160M | 0.83% |
608,735
-79,168
| -12% | -$21.4M |
|
23
Bristol-Myers Squibb
BMY
$131B
| $159M | 0.82% |
2,232,064
+606,788
| +37% | +$44M |
|
24
Chubb
CB
$137B
| $158M | 0.82% |
870,209
+434,799
| +100% | +$82.6M |
|
25
Arch Capital
ACGL
$33.9B
| $158M | 0.82% |
3,466,030
+1,967,730
| +131% | +$88.9M |
|
Similar funds
KK
VAI
UIM
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.